EP1993497A4 - Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity - Google Patents

Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity

Info

Publication number
EP1993497A4
EP1993497A4 EP06720120A EP06720120A EP1993497A4 EP 1993497 A4 EP1993497 A4 EP 1993497A4 EP 06720120 A EP06720120 A EP 06720120A EP 06720120 A EP06720120 A EP 06720120A EP 1993497 A4 EP1993497 A4 EP 1993497A4
Authority
EP
European Patent Office
Prior art keywords
direct application
crosslinking reagents
spinal deformity
progressive spinal
toxic crosslinking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06720120A
Other languages
German (de)
French (fr)
Other versions
EP1993497A1 (en
Inventor
Tom Hedman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hedman Tom
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1993497A1 publication Critical patent/EP1993497A1/en
Publication of EP1993497A4 publication Critical patent/EP1993497A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Surgical Instruments (AREA)
EP06720120A 2006-02-02 2006-02-02 Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity Withdrawn EP1993497A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/003636 WO2007089233A1 (en) 2006-02-02 2006-02-02 Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity

Publications (2)

Publication Number Publication Date
EP1993497A1 EP1993497A1 (en) 2008-11-26
EP1993497A4 true EP1993497A4 (en) 2011-11-09

Family

ID=38327701

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06720120A Withdrawn EP1993497A4 (en) 2006-02-02 2006-02-02 Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity

Country Status (4)

Country Link
EP (1) EP1993497A4 (en)
JP (1) JP2009525327A (en)
CA (1) CA2639976A1 (en)
WO (1) WO2007089233A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070202143A1 (en) * 2001-08-31 2007-08-30 Hedman Thomas P Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints
US8241654B2 (en) * 2008-09-26 2012-08-14 Tyco Healthcare Group Lp Reactive surgical implant
ITRM20090360A1 (en) * 2009-07-13 2011-01-14 Antonio Zuorro ANTIMICROBIAL PREPARATION FOR TOPIC USE IN METHYLGLIOSSAL BASIS
CN110842644B (en) * 2019-11-09 2021-02-02 北京工业大学 Method for monitoring contact stiffness degradation rate of machine tool moving part based on numerical control load information

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040010251A1 (en) * 2001-12-10 2004-01-15 Shahar Pitaru Methods, devices, and preparations for intervertebral disc treatment
US6812211B2 (en) * 2002-03-19 2004-11-02 Michael Andrew Slivka Method for nonsurgical treatment of the intervertebral disc and kit therefor
US20040253219A1 (en) * 2001-08-31 2004-12-16 University Of Southern California Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability
US20050209699A1 (en) * 2002-03-19 2005-09-22 Slivka Michael A Method for nonsurgical treatment of the nucleus pulposus of the intervertebral disc using genipin or proanthrocyanidin, and kit therefor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270446A (en) * 1989-04-04 1993-12-14 Suntory Limited Decolorized crosslinked products and method for decolorization of crosslinked products
CA2270599C (en) * 1996-11-05 2005-06-14 Challenge Bioproducts Co., Ltd. Chemical modification of biomedical materials with genipin
WO2003020031A1 (en) * 2001-08-31 2003-03-13 University Of Southern California Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues
TW200526203A (en) * 2001-08-31 2005-08-16 Univ Southern California Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253219A1 (en) * 2001-08-31 2004-12-16 University Of Southern California Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability
US20040010251A1 (en) * 2001-12-10 2004-01-15 Shahar Pitaru Methods, devices, and preparations for intervertebral disc treatment
US6812211B2 (en) * 2002-03-19 2004-11-02 Michael Andrew Slivka Method for nonsurgical treatment of the intervertebral disc and kit therefor
US20050209699A1 (en) * 2002-03-19 2005-09-22 Slivka Michael A Method for nonsurgical treatment of the nucleus pulposus of the intervertebral disc using genipin or proanthrocyanidin, and kit therefor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2007089233A1 *

Also Published As

Publication number Publication date
JP2009525327A (en) 2009-07-09
EP1993497A1 (en) 2008-11-26
WO2007089233A8 (en) 2008-10-16
CA2639976A1 (en) 2007-08-09
WO2007089233A1 (en) 2007-08-09

Similar Documents

Publication Publication Date Title
EP2126063A4 (en) Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
EP2207509A4 (en) Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
PL3121169T3 (en) Methods of synthesis and/or purification of diaminophenothiazinium compounds
HK1124320A1 (en) Sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles
IL184772A0 (en) Method of bone plate shaping
ZA200706345B (en) Amino-pyridines as inhibitors of ß-secretase
ZA200710174B (en) Methods of purifying tigecycline
EP2117448A4 (en) Spinal anchoring screw
HK1200440A1 (en) Crystalline forms of inhibitor
IL193693A0 (en) Purine compounds and methods of use thereof
EP2035448A4 (en) Neuroactive fragments of app
GB0608190D0 (en) Method of purification
HK1134295A1 (en) Compounds and methods for synthesis and purification of oligonucleotides
EP1971695A4 (en) Recovery of solid magnesium sulfate hydrate
EP2069390A4 (en) Opsin stabilizing compounds and methods of use
GB0900458D0 (en) Estimation of properties of mud
EP1993497A4 (en) Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity
AP2008004565A0 (en) Condenser which is exposed to air
IL193399A0 (en) Novel crystalline forms of armodafinil and preparation thereof
GB0423991D0 (en) Applications of nucleic acid fragments
IL195061A0 (en) Crystalline forms of atorvastatin
GB0618703D0 (en) Synthesis of leikotriene compounds
IL184570A0 (en) Purification of oligonucleotides
GB0608038D0 (en) Fastening of pipes
HU0600117D0 (en) Structure of road

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080901

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HEDMAN, TOM

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HEDMAN, TOM

A4 Supplementary search report drawn up and despatched

Effective date: 20111011

RIC1 Information provided on ipc code assigned before grant

Ipc: A61F 13/00 20060101AFI20111005BHEP

Ipc: A61L 27/54 20060101ALI20111005BHEP

Ipc: A61L 27/50 20060101ALI20111005BHEP

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160901